Saxagliptin and Alogliptin Noninferior for CV Ischemic Events in Patients at High Risk with T2DM and Coronary Disease

Article Information

DOI 
http://dx.doi.org/10.1177/155989771315012
Published By 
SAGE Publications
Print ISSN 
1559-8977
Online ISSN 
2155-756X
Copyright & Usage 
© 2013 MD Conference Express®

Author Information

  1. Emma Hitt Nichols, PhD
  1. Deepak L. Bhatt, MD, MPH
    1. Harvard Medical School and Brigham and Women's Hospital, Boston, Massachusetts, USA (At time of ACC.06 publication, Cleveland Clinic Cardiovascular Coordinating Center, Cleveland, Ohio, USA)
View Full Text

Article usage

AbstractFullPDF
Apr 20151630
May 2015200
Jul 2015100
Aug 2015200
Sep 2015100
Oct 2015132
Nov 2015211
Total2573

Note: Article usage statistics are calculated and reported monthly.

Cited By...

  • No citing articles found.
Back to top

Tools

View Full Page PDF
Citation Tools
Email
Saxagliptin and Alogliptin Noninferior for CV Ischemic Events in Patients at High Risk with T2DM and Coronary Disease
Permalink: Copy
Linkedin Share Button del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo StumbleUpon logo

Table of contents

Cited By...

  • No citing articles found.

Keywords

Cardiology Clinical Trials
Myocardial Infarction
Diabetes Mellitus
Hyperglycemia/Hypoglycemia
Cardiology Clinical Trials
Myocardial Infarction
Diabetes Mellitus
Hyperglycemia/Hypoglycemia